Aquestive Therapeutics Inc (AQST) Form 4 Filed on June 12

Aquestive Therapeutics Inc (AQST) filed a Form 4 on June 12, detailing insider transactions. Such filings are significant as they provide transparency about stock ownership changes and can influence investor sentiment. Investors often scrutinize insider actions for potential insights into the company's future moves. The filing typically includes information such as the number of shares bought or sold by insiders, which can affect trading volumes and market perception.